Welcome to Chimerix

Chimerix discovers, develops and commercializes therapeutics with enhanced pharmaceutical properties that are active against a broad range of viral diseases. Leveraging a powerful lipid prodrug technology, ProLipTag^TM, Chimerix is able to develop drug candidates with oral-availability, increased potency and targeted delivery. These enhanced pharmaceutical properties can be applied to new drug moieties or known drugs to improve dosing parameters, broaden therapeutic applications and decrease the risk of adverse reactions.

Product Pipeline

Product pipeline developed based on the Chimerix technology ProLipTag^TM [more]

Technology Benefits

Leveraging a powerful lipid, pro-drug technology Chimerix is able to develop drug candidates with improved oral-availability. [more]